Global, National and Local Ambassador for Central NJ’s Biotech Message
Hawaii…Winston-Salem, NC…Copenhagen …Piscataway, NJ…

These are just a few of the recent locations where Dr. David Finegold, Dean of the School of Management and Labor Relations at Rutgers is speaking or meeting about New Jersey’s bioscience industry.   With each of these visits leading to countless connections, he’s got Bio-1 well on its way to reaching its goal of making Central New Jersey the next “hot spot” for the global bioscience industry.

Dr. Finegold will be presenting at the 2008 Triple Helix Summit, "The DNA of Collaborative Innovation: Collaborative Models for Innovation & Global Health" February 2-4, 2008 in Hawaii.  The Summit, co-organized between The Institute for Triple Helix Innovation and World Health Organization is a platform where leading representatives from industry, government and academia are able to reach across traditional networks to exchange data, emergent technologies and outcomes to create new trilateral knowledge flows.

Following right after that, Dr. Finegold will travel to Winston-Salem, North Carolina to speak at the Biotechnology Industry Group Institute, a forum for all of the WIRED regions focused on biotechnology.  With him, Bio-1 will send a team to participate in the institute, including Executive Director Mary Ellen Clark, Fiscal Agent Jane Brady, CFO of the Middlesex County WIB and Aaron Fichtner, Director of Research and Evaluation at the Heldrich Institute.  Another partner will be there, too, as Linda Eno, Principle of the Biotechnology High School is also scheduled to speak.

Dr. Finegold has also recently cultivated a strong relationship in Denmark with Medicon Valley Alliance (MVA), a focal point for 12 regions around the world and one of the world’s leading biotech clusters.  Dr. Finegold met in Copenhagen with Stig Jorgensen, Director of MVA, and on February 11th, Andrew Munk, MVA’s International Relations Manager will give a talk in conjunction with the Rutgers Innovation Speakers Forum.  The Bio-1 Executive Committee will join that talk as well.  Check out the link to the Bio-1 website on the Medicon Valley site.

Locally, Dr. Finegold has been a proponent for biotech, too.  In addition to Chairing Bio-1’s Governance Board, serving on the Executive Committee, sponsoring the “Transform Graduate Education” implementation team  and participating on the “Facilitate Global BioBusiness” team, he’s also on the planning committee for a new Technology Park associated with the redevelopment of Rutgers Livingston Campus, which has the potential to support technology commercialization. 

Prior to joining Rutgers, Dr. Finegold was a professor at the Keck Graduate Institute in Claremont, CA and at USC’s Marshall School of Business.  He is the author of more than 90 articles, book chapters and policy reports, and has written or edited six books, including Corporate Boards: Adding Value at the Top (with Jay Conger and Ed Lawler) and BioIndustry Ethics (Elsevier Academic Press, 2005).   He consults and provides executive education and coaching to public and private sector organizations on issues about talent management and employee development, corporate governance, integrating ethics into strategic decision-making, and designing effective organizations.